◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › IRON

Disc Medicine, Inc. (IRON) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Disc Medicine, Inc. (IRON) operates in the Biotechnology industry and is headquartered in Watertown, United States with about 154 employees. Its market capitalization is roughly $3 billion. In the fiscal year ended 2025-12-31, IRON reported $0M in revenue and ($212M) in net income.

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Interactive charts & full statements →

IRON Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$0M$0M$0M$0M
Operating Income (EBIT)($236M)($130M)($91M)($48M)
Net Income($212M)($109M)($76M)($47M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRON Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$0M$0M$0M$0M$0M
Operating Income (EBIT)($70M)($67M)($68M)($61M)($40M)
Net Income($64M)($60M)($62M)($55M)($34M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IRON Free Cash Flow History

IRON Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$807M$497M$368M$200M
Total Liabilities$67M$53M$23M$24M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IRON viewer.

Other Companies in Biotechnology

← IRMDAll stocksIRT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.